NEWSMAX @NEWSMAX
ALZHEIMER'S DRUG BREAKTHROUGH: An experimental Alzheimer's drug from Eisai and Biogen slowed cognitive decline in a closely watched trial but may carry a risk of serious side effects for certain patients. https://t.co/IqnhCvFCNV — PolitiTweet.org